Media

Här hittar du våra pressmeddelanden och mest relevanta nyheter

Pressmeddelanden

Pressmeddelande

- 25.10.2022

Neuraxpharm tar sig in i den digitala hälsomarknaden med en bärbar enhet för epilepsi

Pressmeddelande

- 09.09.2021

Neuraxpharm appoints Philipp Pohoralek as new Country Manager for Germany

Pressmeddelande

- 01.06.2021

Neuraxpharm appoints Dr. Maximilian von Wülfing as COO

Pressmeddelande

- 12.04.2021

Neuraxpharm strengthens European presence in the Nordics

Pressmeddelande

- 08.02.2021

‘Life-changing Minutes’, an initiative to help understand epilepsy

Pressmeddelande

- 28.01.2021

Neuraxpharm selected for prestigious pilot program to supply medical cannabis in France

Pressmeddelande

- 12.01.2021

Neuraxpharm launches first product in Japan

Tillkännagivande

- 16.12.2020

Neuraxpharm announces closing of its acquisition by a company backed by funds advised by Permira

Pressmeddelande

- 14.12.2020

Neuraxpharm establishes operations in the Republic of Ireland through the acquisition of Medinutrix

Pressmeddelande

- 22.09.2020

Permira funds to acquire leading European CNS specialty pharmaceutical company Neuraxpharm

Pressförfrågningar

Om du är journalist med en medieförfrågan, kontakta Neuraxpharm mediekontor genom att fylla i kontaktformuläret

Centrala nervsystemet

Neuraxpharm

Stöd